VINC
VINC is currently in a range/mixed trend, above the 50-day MA but below the 200-day MA. RSI is at 78.1 (overbought), with 1/3 trend checks passing.
VINC with MA50 and MA200
Key levels & signals
VINC valuation multiples (TTM)
VINC analyst consensus
VINC currently looks more uncertain than directional, with a fairly mixed technical picture. The latest available price is $0.02, and 1 of 3 core trend checks are currently passing. Price is trading above the 50-day moving average by 15.9% and below the 200-day moving average by 3.8%.
VINC currently has an RSI reading of 78.1, which points to very strong short-term momentum but also a fairly extended setup. Stocks can stay strong for longer than expected, but this kind of reading often tells beginners not to confuse strength with low-risk entry timing.
Because VINC is showing stronger momentum inside a more extended backdrop, the next step is often about timing rather than direction. A stock can keep pushing higher, but many traders will still watch for whether the move stays orderly or starts to look too stretched to offer a comfortable entry.
About Vincerx Pharma, Inc.
Vincerx Pharma, Inc. is a biopharmaceutical firm currently in the clinical development phase, dedicated to discovering and advancing innovative treatments for cancer, specifically addressing areas of high medical need within the U.S. Its primary therapeutic asset is VIP152, an inhibitor targeting cyclin-dependent kinase-9 (CDK9), designed for individuals battling advanced forms of cancer. Beyond this lead candidate, the company's pipeline features several preclinical-stage projects: VIP217, an orally administered PTEFb/CDK9 inhibitor; VIP236, a small molecule drug conjugate aimed at solid tumor treatment; and VIP943 and VIP924, both geared towards treating blood cancers. Established in 2019, Vincerx Pharma is based in Palo Alto, California.
VINC shares outstanding over time
Tracking total shares outstanding is one way to spot dilution — a rising line means the company has issued more shares (stock-based compensation, secondary offerings, convertible debt), which spreads the same earnings and ownership across more shares. A falling line usually reflects buybacks.
Learn the indicators behind this page
More stock opportunities
Common questions about VINC
Is this page a buy or sell recommendation?
No. This page is designed to help you review chart structure, momentum and technical context more quickly, but it is not personal financial advice.
Why can a stock look bullish and overbought at the same time?
Strong trending stocks can still become stretched in the short term. That is why trend traders and dip buyers can read the same chart differently.
What should I do next after reading this page?
Open the full dashboard, review the chart in more detail, compare indicators, and decide whether the setup still makes sense within your own process.